EyeBio Revenue and Competitors
Estimated Revenue & Valuation
- EyeBio's estimated annual revenue is currently $4.6M per year.
- EyeBio's estimated revenue per employee is $77,500
- EyeBio's total funding is $130M.
Employee Data
- EyeBio has 59 Employees.
- EyeBio grew their employee count by 37% last year.
EyeBio's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Assistant to Chief Medical Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | SVP Clinical Development | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | VP Quality Assurance | Reveal Email/Phone |
6 | SVP Biology | Reveal Email/Phone |
7 | Director, Regional Monitoring (US) | Reveal Email/Phone |
8 | Associate Director, Drug Supply | Reveal Email/Phone |
9 | Director, CMC Drug Substance | Reveal Email/Phone |
10 | Senior Data Manager | Reveal Email/Phone |
EyeBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 20 | 25% | N/A | N/A |
#2 | $14M | 90 | 7% | $149M | N/A |
#3 | $1.3M | 17 | -26% | $9.8M | N/A |
#4 | $2.2M | 28 | 33% | N/A | N/A |
#5 | $2.4M | 31 | -9% | $66.7M | N/A |
#6 | $1.7M | 22 | -4% | $3.86M | N/A |
#7 | $1.4M | 18 | 50% | $2.11M | N/A |
#8 | $0.1M | 1 | 0% | N/A | N/A |
#9 | $4.6M | 59 | 37% | $130M | N/A |
#10 | $27.9M | 144 | -3% | N/A | N/A |
What Is EyeBio?
EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
keywords:N/A$130M
Total Funding
59
Number of Employees
$4.6M
Revenue (est)
37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.2M | 59 | -2% | N/A |
#2 | $13.3M | 59 | 5% | N/A |
#3 | $8.8M | 59 | -18% | N/A |
#4 | $3.5M | 59 | 11% | N/A |
#5 | $7.5M | 59 | -38% | N/A |